{"name":"VM Therapeutics LLC","slug":"vm-therapeutics-llc","ticker":"","exchange":"","domain":"vmllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VMD-3866 Gel","genericName":"VMD-3866 Gel","slug":"vmd-3866-gel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"VMD-3866 Gel","genericName":"VMD-3866 Gel","slug":"vmd-3866-gel","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOR3hVSkUzc3hEUE9ydF9QdnNEU1dialN4SGJwaU5fNXNPc05PMUNfaGtXazJiWUkyZ3BILV96RDUtR0Q3b1hWZE1jMlAzeE9IWEtYcW92STFiR0J3UVRuVGFRcDRfdmZ1Mko5R043SEhDdTByR1NQOXhNdzFnZWRDZnlURUhaZGM1by1WU3FKVzNpMThEYzhtNFh6akF2b1lsOFA4eXE5M3FTaFpveENldTkzOEJPSlZhRG01VjhhcVBRRTZjUU5uMFhqZl90dGRIT0ZaVXo0TkNSUkxpTFJ3c1cxR3ptLU5KM0E?oc=5","date":"2026-04-08","type":"pipeline","source":"VisionMonday.com","summary":"K.C. Pharmaceuticals Issues Voluntary Recall for Over 3 Million Bottles of Eye Drops Citing Sterility Concerns - VisionMonday.com","headline":"K.C. Pharmaceuticals Issues Voluntary Recall for Over 3 Million Bottles of Eye Drops Citing Sterility Concerns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQOC1rZUdZenQtYzgweWFpMFVIQ2FsLWZPRkdwcnFpU0w2TmFyUDUycnhnYzZyS2IyR2l3X3RXOU9fbXJYRWlxb2NyZllRQmdSS29pNjdmU1BnVzZZam1VbVNzSzNpWERYSzdYdFVkWEZlR3NTVm5iOWpDVDZfX05UTmcyZGxwRFRpdzNkcmdlVnFTdGdzU0k4Y1R2NWZRcG1LRThSLXR5OW0wU1NxSF9aYjcxQ0hQVHVNa19MbVd0YzV6RHhJaWlXbVRLWnhMaDNsVk5lRktUcw?oc=5","date":"2026-03-30","type":"pipeline","source":"VisionMonday.com","summary":"NovaBay Pharmaceuticals Announces Corporate Name Change to Stablecoin Development Corporation - VisionMonday.com","headline":"NovaBay Pharmaceuticals Announces Corporate Name Change to Stablecoin Development Corporation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPakNHdTVOajhDVEcxcTN0clpoUHpmc1QxWHJITGtjQmR3VUpGN0RvM1dQTGFiU09sZlJUYkI5MEd1SkFkUWtQQnRXUFE3NU1jWlIyT0dVa21BMHFEaVJmWHVJeHU4eFNCUjFNZzg2RUFSVzRsQzU0U1ZpNEhta09kRTh3cEMyVEExUjZkUnN4SkNKQnh2ZHhSNlNrSzdFQzd5cTY2Wl9MaXdYMWlUcXFLOWJnbTdBX0l6bjJtaEVMN0tfSGFfZkRr?oc=5","date":"2026-02-25","type":"earnings","source":"VisionMonday.com","summary":"Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - VisionMonday.com","headline":"Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOUEh4U3VMbV93a3lMTTBSYmMzYVJXOWtFQTdjcUtKTUdEQXdpb3FhaG5udTZiZnpnX3hCM3BhUE9zcUJFVURUSl9qV1hZWWRVUEstLXN2WDdMbkJIS1d2ODZVZ0dxLVE1ZFM2SGNaWDVPZGJjbmZpeWh2TE0zYWpKT0p0OG00LVNuaU1UbWxNdWRVQnpfRTJ6UTBKM3R1QTZNYmJMUFA5M09Ddkh1ZVE5SzhQV3BFdw?oc=5","date":"2026-02-20","type":"pipeline","source":"VisionMonday.com","summary":"Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors - VisionMonday.com","headline":"Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNMndHSGFNN3JtYW1BWFpweHE3a29wZkFDV3EycXhrLUxjaE9NekJ6azNxNTlVbkl2UklfRGJ6RHU2MEU0QllQT2NKa1BMWEhnc2FOczFNNmMtc280MDF1YjNWSUhJRXNNb2FwU3NLb2l3RWxjQTBZNDBRR1dJTXljOVM1SS1ycDVOZnphc1JzWUxIQmxwTWlwc2dwQ3R6RENTZFpoOVFHa0ltbk5FemRxZWhvdjg3c1NLMnhfNXpHaw?oc=5","date":"2026-01-09","type":"earnings","source":"VisionMonday.com","summary":"LENZ Therapeutics Reports Preliminary Q4 2025 Results, Highlights VIZZ Launch - VisionMonday.com","headline":"LENZ Therapeutics Reports Preliminary Q4 2025 Results, Highlights VIZZ Launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSVlaY0hOWWdlOHlzSnVTcmhELUc2bi1fVzFHMTNlVHdnUHpIajI0dFFBa3lvY3l6eFMxNkNvd255OTBhS2tpR1hlV3JFMHpRWGliblNhVXpGTHowY2VPVHhnX0tKZFNTcFRPSTZaREVFenBCWVhTYmloRHNXci1Zd1V3Z0dRcW0yNmptcmJuZXBndk1QZEwwZjVjVUlobVVJeVNieQ?oc=5","date":"2025-11-19","type":"pipeline","source":"VisionMonday.com","summary":"Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com","headline":"Harrow Completes Its Acquisition of Melt Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPYjg2Z1otR1FWaTZlQy1Kd0ZqTk1xSHJFTnFfNHA2M3ptZWptNW94QjQ1UnJGZVFrdjhtRDRNT0JFQ0c3SGVaSTg4bzNYbTRtb29FdVV3MU5Fa2dmWjl0dVFETGduWkpBS0tDZ19vaE8zOGlCTVBPSVgyZ1hMQXdsakRMcjhvZWhadFZSMmFRS1c0M2thWTNsc2xaWEpYb2l3SFdqOEdiRXZQUVRLaGdTU2FXZm9mR244cndrcHVxb1pBcmc5T1R5OTc1R0N4eFU3MC1OME4xWUdHZ0QtdGlyamRsSnpLbUpkWUJKZ0pocDk?oc=5","date":"2025-10-23","type":"pipeline","source":"InvestorNews","summary":"Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Wall Street Expertise to Facilitate U.S. Market Expansion - InvestorNews","headline":"Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Wall Street Expertise to Facilitate U.S. Market Expans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxOQnVMZjBIMnRadVZZWkJTZGdNU3E0YkV6blU4ZTZwbEVuV09udVJvZDEzTFRmcjhjb1NhRDctNktxUHA1SmViU0xNYVNZejhOUS1XeFJVR3A2VzQ2MjAweE9EdHJJVzhMV0cxYUM0eF9CV0drVXhwbmQ2bHF2YzE5U2M5V0I5cUhtMXdFM1NjckE1dGhXR21uMzBfeWtaWEtkMkdkZnFZd1NDc3NldFFmVndCUEF3elRtNUJGMUpkLWF0UV9ITHpTOURBVS1KY3ZTN24tMWMzMlEyaGdVUXlLZ2JFRE5wWHhUODVFRGxfQlJTSXVkeTMtclBIbXVSQjJEdGxOSHFYdmxvRmtYUDN5RDdIY1NaRmZhQlpORm1oeXo1alRXbzh6SVUzT25SUlhWN3RXMkJJX1dFS2MyTF8wVjZzVGRqNkU?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire","summary":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight - PR Newswire","headline":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Dia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQazhDSTlmeHJGWVcyMHFTc0RrMGQzSmdORnoxbTZQQU93RHZNU0k2SEwxZUVzUE1UOVZCN2lCODBibTM4bXdNRFpKbW92MFBhVloyMUtsX1lZc1pJbzJYRUNhRjBPQlNfT1EtcFpDejBOTEVpcU01RXpNc2NlN2VzdHd2LUJjREhKQjM0RUdkSWtsTV9sTXd0WE5RR3Z2c3pEYXZKb0lhQ0YyeFNDVGZBT0pB?oc=5","date":"2025-10-16","type":"pipeline","source":"VisionMonday.com","summary":"EyePoint Pharmaceuticals Sets Pricing of Its Public Stock Offering - VisionMonday.com","headline":"EyePoint Pharmaceuticals Sets Pricing of Its Public Stock Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZGtWZHFNbTBHS1YyTU1ENWd4Y09VQ3ZPbWQ2NmZyUHlVbl8zdU5JR1hwbl9aN2xQdlNHaWNSdWV4cjlOdEhHMGVSeEtkaWlVOFN5dGRZZHRHLUN4b1dBUmFGNGVIcWhTTi1NTnNnb00yUDlkLXRzTWVtTFZyT1ozbUtGTmxlUnZzZmEwQkZXSEVIXzR1VkxDWlluLVRXR0tDdTZteTQ0V2ZFbGM3TmJjVWM1TEI4MUlHWnRCOEwydmx6YUtreVMybWJoUWxkSkZtb3dYb1VJNjVLSTdFNWotdGY1ZnlxdnNRWkt1Q2VCeGVvbVpfUWptOXlISkhNZ01FQWF3Zks5YWVJQ0FVYkVpV2x1TnVTdVpK?oc=5","date":"2025-06-09","type":"regulatory","source":"PR Newswire","summary":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOalVSZzZDdmhYeDhzS1J5bjc5MXl2X3B5cDJsYVFNN3J2RjFXN1lNazBkSzVJcm0xRUtUZWVLS2tVLVhWckt3TW54a2pXYzZpOHdMWm1oSHhGTGhYc3JNbWtYQjdpWUhZc3RSYzY4TDV5cXpDOXRHZmZTR0hQT3o1bjlDUTB1clNvM2pSSml3bWZjUXZMUkVNYnF0WE9pWTJ4NERNUnRRZ1dEeElZcktUUFBtMmt1dzk3cUNnb0lkampnV3RHZUJkTVQxa0xTNkhIWjA2akVFd1d1SmZB?oc=5","date":"2024-03-13","type":"pipeline","source":"Proactive financial news","summary":"Voyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon - Proactive financial news","headline":"Voyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTGExV1FFOTQxRVIyLXc5VkxhZUFaMGJIWXJFUFdsM1NtSVZnaVBEVDNxMzhjM01meHlaVG0zVGhSTEEzLXVMQmNWd1J6SlFrOGoyeTlpdkNyTXp2aWJobWhLc1hEbkpKTkRNb3N4U3dsMWl0ajVrcnJYd0V4Skxrb19QZTk5RnkyTnBxZ3pDMm5nZ2RMd3BubXNMQlhnNWlwVXF5VW5HSTc0TVFIU3NJZ2ZIUFQzN1d0aUhQTGxBMlg5ejhsVEZSNw?oc=5","date":"2015-09-08","type":"pipeline","source":"PR Newswire","summary":"Purdue Pharma L.P. Announces Acquisition of TrkA Program from VM Pharma LLC - PR Newswire","headline":"Purdue Pharma L.P. Announces Acquisition of TrkA Program from VM Pharma LLC","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}